Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all

ConclusionCurrent literature evidence is limited to rationally support the use of montelukast in atopic dermatitis treatment. For now, the conventional treatments should be preferred in the clinical setting.

Source: Journal of Clinical Pharmacy and Therapeutics - November 8, 2017 Category: Drugs & Pharmacology Authors: W. K. Chin Tags: COMMENTARY Source Type: research